AzTrials
AzTrials

Diet, Food and NutritionDURIOMENCT06194084

Impacts of Durian Consumption on Human Microbiome and Metabolome in Healthy Staff Volunteers

A study testing Two-sequence of durian pulp doses (100 g and 200 g) in people with Diet, Food and Nutrition, run by National Cancer Centre, Singapore at 1 site in Singapore.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This clinical study investigates the impacts of daily durian consumption on gut microbiota, gut microbial metabolites, and host metabolome in healthy individuals. Read more about this study

Who is it for?
Ages 21 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Diet, Food and Nutrition
What is being tested?
Two-sequence of durian pulp doses (100 g and 200 g)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
1 siteSingapore
Study dates
1 Feb 2023to 29 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male and/or female subjects between the ages of 21 and 60 years, inclusive
  • Willing and able to provide written informed consent
  • Must be in generally good health with clinically insignificant screening results (Fasting plasma glucose level \& Lipid profile), as determined by the Investigator
  • Agrees to consume durian for 2 weeks
  • Agrees to maintain a low-fiber diet during the intervention
  • Have not received any antibiotics therapy, consumed prebiotics, probiotics, symbiotic /vitamin supplement, and/or TCM for at least 1 month before the start of the study
  • Have not received any medical treatment that would impact on intestinal microbiota at least 6 months before the start of the study or during the study
  • Recent COVID-19 vaccination received or infection with COVID-19 at least 2 months ago

Who cannot join

  • Known or suspected sensitivity/allergy to durian
  • Multiple food/drug allergies
  • Smoker
  • History or presence of current metabolic conditions and gastrointestinal diseases
  • Diagnosed with Inflammatory Bowel Disease (IBD) or significant liver enzyme abnormality
  • Presence of current haemorrhoids or piles causing rectal bleeding when passing stool
  • Pregnant, breastfeeding or intending to conceive during study period

Trial locations and contacts

1 site in 1 country.

Singapore1 site
  • National Cancer Centre, Singapore

    Singapore, 168583

Other trials in Singapore

About this study

Official title: Precision Nutrition - Impacts of Durian Consumption on Human Microbiome and Metabolome in Healthy Staff Volunteers From SingHealth

This clinical study investigates the impacts of daily durian consumption on gut microbiota, gut microbial metabolites, and host metabolome in healthy individuals.

Read the detailed description

Participants will go through an initial washout maintaining a low-fiber diet for 14 days. After washout, participants will be instructed to consume 100 grams of durian pulp every day following their breakfast or dinner for 1 week. Participants will then continue to consume 200 grams of durian pulp every day during the 2nd week of intervention and then will go through another washout for 2 weeks. During the intervention period, participants will be informed to maintain low-fiber diet. All participants will be required to note down their stool consistency and stool frequency and 3-days dietary records. Stool and blood samples will be collected at 4 time points during the study period (baseline, 1-week of intervention, 2-weeks of intervention and 2-weeks washout) and will be stored at -80 °C until analysis.

The first outcomes of this study will provide insights into the interplay between durian consumption, gut microbiome, and host metabolome, as well as whether durian consumption can improve the clinical parameters (plasma glucose levels, lipid profiles and HbA1c levels) of healthy subjects. The interplay between diets, gut microbiome, host metabolome and genetic polymorphism data in healthy population will lay the groundwork to develop the precision nutrition strategy based on our regional food. These findings have potential to improve the health and well-being of the communities in our region.

Being tested
Two-sequence of durian pulp doses (100 g and 200 g)
Keywords
Precision Nutrition, Durian, Gut Microbiome, Metabolome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Two-sequence of durian pulp doses (100 g and 200 g)Other

    Participants first go through an initial washout maintaining a low-fiber diet for 14 days. After washout, participants will be instructed to consume 100 grams of durian pulp every day following their breakfast or dinner for 1 week. Participants will then continue to consume 200 grams of durian pulp every day during the 2nd week of intervention and then will go through another washout for 2 weeks.

Study groups in NCT06194084
Study groupRoleWhat they receive
Intervention - durian pulp.ExperimentalTwo-sequence of doses (100 g and 200 g) of durian pulp.
Receives: Other: Two-sequence of durian pulp doses (100 g and 200 g)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fasted Blood Glucose

    Changes in Fasted Blood Glucose (mg/dL), before \& after Durian intervention.

    Measured: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  2. HbA1C

    Changes in HbA1C (%) before \& after Durian intervention.

    Measured: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  3. Total Cholesterol

    Changes in Total Cholesterol (mg/dL) before \& after Durian Intervention.

    Measured: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  4. HDL Cholesterol

    Changes in HDL Cholesterol (mg/dL) before \& after Durian intervention.

    Measured: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  5. LDL Cholesterol

    Changes in LDL Cholesterol (mg/dL) before \& after Durian intervention.

    Measured: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  6. Cholesterol/HDL Ratio

    Changes in Cholesterol/HDL ratio before \& after Durian intervention.

    Measured: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  7. Triglycerides

    Changes in Triglycerides (mg/dL) before \& after Durian intervention.

    Measured: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  8. Carbohydrates

    Food record for carbohydrate intake.

    Measured: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  9. Protein

    Food record for protein intake.

    Measured: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  10. Fats

    Food record for fat intake.

    Measured: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  11. Dietary Fibre

    Food record for dietary fibre intake.

    Measured: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  12. Cholesterol

    Food record for cholesterol intake.

    Measured: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  13. Sodium

    Food record for sodium intake.

    Measured: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  14. Sugar

    Food record for sugar intake.

    Measured: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

Secondary outcomes (2)
  1. Changes in gut microbiome composition before and after Intervention.

    The effect of intervention on alpha and beta diversity of the fecal microbial community will be evaluated by 16s sequencing (using illumina MiSeq platforms) of feal bacterial DNA at baseline and after each intervention period.

    Measured: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  2. Changes in metabolomes before and after Intervention.

    Changes in the plasma metabolomics will be evaluated via LC-QTOF-MS to identify the metabolomic markers at baseline and after each intervention period. Whereas changes in fecal microbial metabolomic will be determined via GC-QTOF-MS at baseline and after each intervention period.

    Measured: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jan 2024
  2. Study start1 Feb 2023
  3. Primary completion29 Aug 2025
  4. Study completion29 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
45 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06194084
Sponsor's protocol ID
DURIOME
Acronym
DURIOME
Status last verified
Sep 2025
First submitted
23 Nov 2023
Last updated
1 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Two-sequence of durian pulp doses (100 g and 200 g) in people with Diet, Food and Nutrition, run by National Cancer Centre, Singapore at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fasted Blood Glucose (time frame: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).). The study lists 14 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in